Literature DB >> 15479873

Nuclear factor (NF)-kappaB proteins: therapeutic targets.

I M Verma1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15479873      PMCID： PMC1766777          DOI： 10.1136/ard.2004.028266

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  47 in total

1.  IkappaB family members function by different mechanisms.

Authors:  W F Tam; R Sen
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

Review 2.  NF-kappaB: a key role in inflammatory diseases.

Authors:  P P Tak; G S Firestein
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways.

Authors:  N Inohara; T Koseki; J Lin; L del Peso; P C Lucas; F F Chen; Y Ogura; G Núñez
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

Review 4.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.

Authors:  A Devin; Y Lin; S Yamaoka; Z Li; M Karin
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100.

Authors:  G Xiao; E W Harhaj; S C Sun
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

7.  X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.

Authors:  R Döffinger; A Smahi; C Bessia; F Geissmann; J Feinberg; A Durandy; C Bodemer; S Kenwrick; S Dupuis-Girod; S Blanche; P Wood; S H Rabia; D J Headon; P A Overbeek; F Le Deist; S M Holland; K Belani; D S Kumararatne; A Fischer; R Shapiro; M E Conley; E Reimund; H Kalhoff; M Abinun; A Munnich; A Israël; G Courtois; J L Casanova
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

8.  NEMO/IKK gamma-deficient mice model incontinentia pigmenti.

Authors:  M Schmidt-Supprian; W Bloch; G Courtois; K Addicks; A Israël; K Rajewsky; M Pasparakis
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

9.  IKKalpha controls formation of the epidermis independently of NF-kappaB.

Authors:  Y Hu; V Baud; T Oga; K I Kim; K Yoshida; M Karin
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

10.  NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes.

Authors:  K Aupperle; B Bennett; Z Han; D Boyle; A Manning; G Firestein
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422
View more
  42 in total

1.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Authors:  Emilie Jacque; Thierry Tchenio; Guillaume Piton; Paul-Henri Romeo; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

3.  Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.

Authors:  Wei-Choong Ch'ng; Noraini Abd-Aziz; Meng-Hua Ong; Eric J Stanbridge; Norazizah Shafee
Journal:  Cell Oncol (Dordr)       Date:  2015-05-01       Impact factor: 6.730

Review 4.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

5.  Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.

Authors:  S Cuzzocrea; C Crisafulli; E Mazzon; E Esposito; C Muià; M Abdelrahman; R Di Paola; C Thiemermann
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

6.  Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization.

Authors:  Paola Bargagna-Mohan; Padma Priya Ravindranath; Royce Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-09       Impact factor: 4.799

7.  Anti-aging effects of guanosine in glial cells.

Authors:  Débora Guerini Souza; Bruna Bellaver; Larissa Daniele Bobermin; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2016-09-01       Impact factor: 3.765

8.  Tea polyphenols inhibit cyclooxygenase-2 expression and block activation of nuclear factor-kappa B and Akt in diethylnitrosoamine induced lung tumors in Swiss mice.

Authors:  Preeti Roy; Nidhi Nigam; Madhulika Singh; Jasmine George; Smita Srivastava; Hasnain Naqvi; Yogeshwer Shukla
Journal:  Invest New Drugs       Date:  2009-06-11       Impact factor: 3.850

9.  NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells.

Authors:  Ricardo Parrondo; Alicia de las Pozas; Teresita Reiner; Priyamvada Rai; Carlos Perez-Stable
Journal:  Mol Cancer       Date:  2010-07-09       Impact factor: 27.401

10.  Pterostilbene induces Nrf2/HO-1 and potentially regulates NF-κB and JNK-Akt/mTOR signaling in ischemic brain injury in neonatal rats.

Authors:  Qinghuang Zeng; Wenchang Lian; Guizhi Wang; Manping Qiu; Lingmu Lin; Renhe Zeng
Journal:  3 Biotech       Date:  2020-04-04       Impact factor: 2.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.